News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
76,813 Results
Type
Article (5094)
Company Profile (12)
Press Release (71707)
Multimedia
Podcasts (6)
Webinars (1)
Section
Business (23003)
Career Advice (125)
Deals (3079)
Drug Delivery (19)
Drug Development (11028)
Employer Resources (11)
FDA (1727)
Job Trends (2117)
News (38128)
Policy (2851)
Tag
2024 BioForest Digital (1)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
Academia (600)
Accelerated approval (1)
Adcomms (2)
Allergies (13)
Alliances (6162)
ALS (13)
Alzheimer's disease (288)
Antibody-drug conjugate (ADC) (12)
Approvals (1756)
Artificial intelligence (48)
Autoimmune disease (1)
Automation (2)
Bankruptcy (19)
Best Places to Work (1957)
Biosimilars (5)
Biotechnology (10)
Bladder cancer (8)
Brain cancer (3)
Breast cancer (39)
Cancer (325)
Cardiovascular disease (43)
Career advice (112)
Career pathing (6)
CAR-T (16)
Cell therapy (63)
Cervical cancer (5)
Clinical research (8922)
Collaboration (158)
Compensation (6)
COVID-19 (320)
CRISPR (14)
C-suite (54)
Cystic fibrosis (107)
Data (406)
Denatured (5)
Depression (3)
Diabetes (37)
Diagnostics (749)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (4)
Drug discovery (20)
Drug pricing (9)
Duchenne muscular dystrophy (23)
Earnings (6590)
Editorial (5)
Employer branding (2)
Employer resources (10)
Events (10564)
Executive appointments (157)
FDA (1915)
Featured Employer (5)
Friedreich's ataxia (1)
Frontotemporal dementia (2)
Funding (198)
Gene editing (25)
Generative AI (5)
Gene therapy (47)
GLP-1 (149)
Government (505)
Guidances (7)
Healthcare (2769)
IgA nephropathy (7)
Immunology and inflammation (21)
Indications (9)
Infectious disease (346)
Inflammatory bowel disease (48)
Inflation Reduction Act (2)
Influenza (11)
Intellectual property (16)
Interviews (13)
IPO (1526)
IRA (2)
Job creations (233)
Job search strategy (98)
Labor market (3)
Layoffs (43)
Leadership (2)
Legal (450)
Liver cancer (13)
Lung cancer (45)
Lymphoma (22)
Management (3)
Manufacturing (39)
MASH (46)
Medical device (1217)
Medtech (1218)
Mergers & acquisitions (1625)
Metabolic disorders (117)
Multiple sclerosis (4)
NASH (19)
Neurodegenerative disease (17)
Neuropsychiatric disorders (1)
Neuroscience (393)
NextGen: Class of 2025 (973)
Non-profit (2432)
Northern California (378)
Now hiring (1)
Obesity (41)
Opinion (31)
Ovarian cancer (13)
Pain (6)
Pancreatic cancer (10)
Parkinson's disease (56)
Partnered (3)
Patents (32)
Patient recruitment (13)
Peanut (9)
People (9046)
Pharmaceutical (4)
Pharmacy benefit managers (1)
Phase I (2641)
Phase II (4258)
Phase III (2942)
Pipeline (207)
Policy (9)
Postmarket research (282)
Preclinical (1212)
Press Release (15)
Prostate cancer (15)
Psychedelics (2)
Radiopharmaceuticals (21)
Rare diseases (161)
Real estate (491)
Recruiting (2)
Regulatory (2204)
Reports (3)
Research institute (572)
Resumes & cover letters (15)
RNA editing (1)
RSV (10)
Schizophrenia (12)
Series A (34)
Series B (19)
Sickle cell disease (11)
Southern California (326)
Special edition (2)
Spinal muscular atrophy (83)
Sponsored (5)
Startups (582)
Supply chain (7)
Tariffs (2)
The Weekly (1)
United States (3101)
Vaccines (65)
Venture capitalists (5)
Weight loss (22)
Women's health (2)
Worklife (2)
Date
Today (14)
Last 7 days (99)
Last 30 days (352)
Last 365 days (4553)
2025 (1516)
2024 (4911)
2023 (5669)
2022 (6766)
2021 (7817)
2020 (7535)
2019 (7003)
2018 (5198)
2017 (3994)
2016 (3933)
2015 (4100)
2014 (2888)
2013 (2130)
2012 (2115)
2011 (2182)
2010 (1642)
Location
Africa (96)
Alabama (2)
Alaska (2)
Arizona (11)
Arkansas (1)
Asia (3980)
Australia (742)
California (857)
Canada (210)
China (52)
Colorado (26)
Connecticut (81)
Delaware (22)
Europe (10149)
Florida (97)
Georgia (49)
Idaho (8)
Illinois (77)
India (3)
Indiana (35)
Iowa (3)
Japan (33)
Kansas (10)
Kentucky (6)
Maine (5)
Maryland (105)
Massachusetts (627)
Michigan (20)
Minnesota (27)
Missouri (19)
Montana (8)
Nebraska (6)
Nevada (10)
New Hampshire (9)
New Jersey (206)
New Mexico (5)
New York (247)
North Carolina (168)
North Dakota (1)
Northern California (378)
Ohio (33)
Oklahoma (2)
Oregon (4)
Pennsylvania (188)
Rhode Island (10)
South America (105)
South Carolina (3)
South Dakota (1)
Southern California (326)
Tennessee (5)
Texas (118)
Utah (25)
Virginia (16)
Washington D.C. (9)
Washington State (58)
West Virginia (1)
Wisconsin (3)
76,813 Results for "cystic fibrosis foundation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
European Commission Approves Expanded Label for KAFTRIO® in Combination With Ivacaftor for People With Cystic Fibrosis
April 7, 2025
·
6 min read
Earnings
Vertex Tops Q3 Forecast on Strength of Cystic Fibrosis Sales, Raises Full-Year Revenue Guidance
Coming off of a strong third quarter, Vertex Pharmaceuticals is nearing several important milestones, including the potential approvals of vanzacaftor triple in cystic fibrosis and the non-opioid therapy suzetrigine in pain—both slated for January 2025.
November 5, 2024
·
2 min read
·
Tristan Manalac
Press Releases
ReCode Therapeutics Announces Additional Funding From the Cystic Fibrosis Foundation to Accelerate Development of Novel Gene Correction Therapeutics to Treat Cystic Fibrosis
November 18, 2024
·
4 min read
Genetown
Prime Medicine Receives Up to $15 Million from Cystic Fibrosis Foundation to Advance Hotspot and PASSIGE™ Prime Editors for Cystic Fibrosis
Prime Medicine, Inc. (Nasdaq: PRME) today announced that the Cystic Fibrosis Foundation (CF Foundation) has agreed to provide the Company with up to $15 million to support the development of Prime Editors for the treatment of Cystic Fibrosis (CF).
January 25, 2024
·
6 min read
Press Releases
FDA Grants Orphan Drug Designation to Revolutionary Cystic Fibrosis Therapy
February 26, 2025
·
3 min read
Press Releases
ReCode Therapeutics Receives U.S. FDA Orphan Drug Designation for RCT2100 for the Treatment of Cystic Fibrosis
March 26, 2025
·
3 min read
Cystic Fibrosis
Cystic Fibrosis Biotech Sionna Announces $150M IPO
The Massachusetts-based biotech plans to use the funds to push its candidates into mid-stage clinical trials in a space dominated by Vertex.
February 3, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases
Vertex Researcher, Paul Negulescu Ph.D., Receives the 2025 Canada Gairdner International Award for Pioneering Research and Discovery of Medicines for Cystic Fibrosis
April 14, 2025
·
4 min read
BioCapital
Cystic Fibrosis Foundation Funds Up to $15 Million to Prime Medicine to Pursue Gene Editing in CF
Today, the Cystic Fibrosis Foundation announced that it will provide up to $15 million to Prime Medicine for preclinical research into gene editing for cystic fibrosis.
January 25, 2024
·
3 min read
Press Releases
Boehringer Ingelheim and partners start clinical development of a first-in-class, inhaled gene therapy for people with cystic fibrosis
February 21, 2025
·
8 min read
1 of 7,682
Next
